SCHEMBL25818549

SCHEMBL25818549

Clc1nc(-c2cccc(-c3ccc4cc(-c5cccc6ccccc56)ccc4c3)c2)nc(-c2ccc3c(c2)sc2ccccc23)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 8/20 0.37
S1PR4 O95977 6/20 0.37
F9 P00740 1/20 0.35
ALOX5 P09917 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
CYP1A2 P05177 3/20 0.33
ALDH1A1 P00352 2/20 0.33
RAB9A P51151 2/20 0.33
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 2/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PIM1 P11309 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP2C19 P33261 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818482 0.97 S1PR5 (0.39) S1PR5S1PR4F9ALOX5CA12
SCHEMBL25818468 0.96 S1PR5 (0.38) S1PR5S1PR4F9ALOX5CYP1A2
SCHEMBL25818453 0.91 ALDH1A1 (0.36) S1PR5S1PR4CYP1A2ALDH1A1RAB9A
SCHEMBL22161556 0.90 F9 (0.36) S1PR5S1PR4F9ALOX5CA12
SCHEMBL25818432 0.90 ALDH1A1 (0.37) F9ALDH1A1RAB9AMAPTHPGD
SCHEMBL25818476 0.89 S1PR5 (0.36) S1PR5S1PR4F9ALOX5CA12
SCHEMBL22914375 0.88 ALDH1A1 (0.38) F9ALOX5CA12CA1CA2
SCHEMBL25818483 0.88 KDM4E (0.34) F9ALOX5CA12CA1CA2
SCHEMBL25817796 0.88 S1PR5 (0.42) S1PR5S1PR4F9ALOX5CYP1A2
SCHEMBL25818529 0.88 ALDH1A1 (0.34) CYP1A2ALDH1A1RAB9ACYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 S1PR5 4785/4885S1PR4 4450/4885F9 1377/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 S1PR5 4785/4885S1PR4 4450/4885F9 1377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.